[Dimexide (dimethylsulfoxide) in the treatment of multiple sclerosis].
Thirty-four patients with multiple sclerosis were treated with dimexide. The use of the drug was found to be desirable, since it had a positive effect on immunity and antiallergic and reparative action on the injured tissues. The treatment proved most effective in patients with a remitting course of the disease. In patients with a rapidly progressive course, the improvement was unstable. No side-effects were observed. The beneficial therapeutic effect of dimexide may be explained by remyelinization, a reduction in the edema and neurodynamic improvement.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D001688:Biological Products / Q000627:therapeutic use; D004121:Dimethyl Sulfoxide / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy*; D015002:Yeast, Dried / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D001688:Biological Products; D004338:Drug Combinations; C003221:proper-myl; D004121:Dimethyl Sulfoxide
Dimeksid (dimetilsul'foksid) v lechenii bol'nykh rasseiannym sklerozom.